Please use this identifier to cite or link to this item: https://scholarbank.nus.edu.sg/handle/10635/132528
Title: Hepatitis B vaccination: Half dose recombinant DNA hepatitis B vaccine (B-Hepavac II) is as immunogenic as the full recommended dose in healthy adults
Authors: Guan, R. 
Yap, I. 
Tay, H.H. 
Issue Date: 1991
Citation: Guan, R., Yap, I., Tay, H.H. (1991). Hepatitis B vaccination: Half dose recombinant DNA hepatitis B vaccine (B-Hepavac II) is as immunogenic as the full recommended dose in healthy adults. Journal of Gastroenterology and Hepatology 6 (4) : 374-376. ScholarBank@NUS Repository.
Abstract: Sixty-seven healthy adult volunteers aged 20-40 years with no previous exposure to hepatitis B virus were randomized to receive either a 10 μg or 5 μg dose of recombinant DNA hepatitis B (HB) vaccine (B-Hepavac II) intramuscularly at 0, 1 and 6 months. Two months after the third injection 100% of subjects had seroconverted: 97% of the 10 μg group and 91% of the 5 μg group had antibody to HB surface antigen (anti-HBs) levels greater than 10 iu/L. The geometric mean titres (GMT) of anti-HBs levels at this time were 891 iu/L in the 10 μg dose group and 923 iu/L in the 5 μg dose group. These differences were not significant. Adverse effects included fever and mild pain at the injection site. The reduced dose of 5 μg was as effective as the standard 10 μg dose.
Source Title: Journal of Gastroenterology and Hepatology
URI: http://scholarbank.nus.edu.sg/handle/10635/132528
ISSN: 08159319
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

Page view(s)

12
checked on May 17, 2019

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.